Archives
- Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events 1 November, 2022
- Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates 30 September, 2022
- July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio 1 August, 2022
- May 2022, o2h Ventures Fund Newsletter, SEIS fund close deadline June 30th 2022 28 May, 2022
- The “o2h human health KI EIS fund” makes an investment into Neurocentrx 12 May, 2022
- o2h Ventures Deal Pipeline, KI EIS Fund closing on 5th April 2022 22 March, 2022
- The “o2h human health SEIS fund” makes an investment into Neucruit 18 February, 2022
- o2h Ventures makes a follow-on investment into Oxford Drug Design 18 February, 2022
- o2h Ventures makes an investment into Xploro from “the o2h human health SEIS fund” 16 February, 2022
invest in the growth potential of UK life science & AI